Literature DB >> 10543756

Emergence and dissemination of quinolone-resistant Escherichia coli in the community.

J Garau1, M Xercavins, M Rodríguez-Carballeira, J R Gómez-Vera, I Coll, D Vidal, T Llovet, A Ruíz-Bremón.   

Abstract

We studied the evolution of resistance to quinolones in Escherichia coli from 1992 to 1997 in Barcelona, Spain. An increasing proportion of quinolone-resistant E. coli (QREC) infections was observed. QREC strains were more common in patients with nosocomial infections but also increased in patients with community-acquired infections (9% in 1992 to 17% in 1996). Seventy (12%) of 572 episodes of E. coli bacteremia were due to QREC. Factors significantly associated with QREC bacteremia were the presence of underlying disease, recent exposure to antibiotics, and bacteremia of unknown origin. In the multivariate analysis, only prior exposure to antimicrobial agents (P < 0.001; odds ratio [OR] = 2), specifically, to quinolones (P < 0. 001; OR = 14), and the presence of a urinary catheter (P < 0.001; OR = 2) were significantly associated with QREC bacteremia. Among 16 QREC isolates from cultures of blood of community origin selected at random, 13 different pulsed-field gel electrophoresis patterns were recognized, showing the genetic diversity of these isolates and in turn indicating the independent emergence of QREC in the community. The prevalence of QREC in the feces of healthy people was unexpectedly high (24% in adults and 26% in children). A survey of the prevalence of QREC of avian and porcine origin revealed a very high proportion of QREC in animal feces (up to 90% of chickens harbored QREC). The high prevalence of QREC in the stools of healthy humans in our area could be linked to the high prevalence of resistant isolates in poultry and pork.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10543756      PMCID: PMC89552     

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  18 in total

1.  Association with prior fluoroquinolone therapy of widespread ciprofloxacin resistance among gram-negative isolates in a Veterans Affairs medical center.

Authors:  R R Muder; C Brennen; A M Goetz; M M Wagener; J D Rihs
Journal:  Antimicrob Agents Chemother       Date:  1991-02       Impact factor: 5.191

Review 2.  Mechanisms of resistance to quinolones and clinical perspectives.

Authors:  L J Piddock; R Wise
Journal:  J Antimicrob Chemother       Date:  1989-04       Impact factor: 5.790

3.  The emergence of highly fluoroquinolone-resistant Escherichia coli in community-acquired urinary tract infections.

Authors:  J M Aguiar; J Chacon; R Canton; F Baquero
Journal:  J Antimicrob Chemother       Date:  1992-03       Impact factor: 5.790

4.  Rapid pulsed-field gel electrophoresis protocol for typing of Escherichia coli O157:H7 and other gram-negative organisms in 1 day.

Authors:  R K Gautom
Journal:  J Clin Microbiol       Date:  1997-11       Impact factor: 5.948

5.  Epidemiology of severe hospital-acquired infections in patients with liver cirrhosis: effect of long-term administration of norfloxacin.

Authors:  B Campillo; C Dupeyron; J P Richardet; N Mangeney; G Leluan
Journal:  Clin Infect Dis       Date:  1998-05       Impact factor: 9.079

6.  The carriage of Escherichia coli resistant to antimicrobial agents by healthy children in Boston, in Caracas, Venezuela, and in Qin Pu, China.

Authors:  S C Lester; M del Pilar Pla; F Wang; I Perez Schael; H Jiang; T F O'Brien
Journal:  N Engl J Med       Date:  1990-08-02       Impact factor: 91.245

Review 7.  Social, behavioral, and practical factors affecting antibiotic use worldwide: report of Task Force 4.

Authors:  C M Kunin; H L Lipton; T Tupasi; T Sacks; W E Scheckler; A Jivani; A Goic; R R Martin; R L Guerrant; V Thamlikitkul
Journal:  Rev Infect Dis       Date:  1987 May-Jun

8.  Animal to man transmission of Enterobacteriaceae.

Authors:  A H Linton
Journal:  R Soc Health J       Date:  1977-06

9.  Prevalence of bacterial resistance to quinolones and other antimicrobials among avian Escherichia coli strains isolated from septicemic and healthy chickens in Spain.

Authors:  J E Blanco; M Blanco; A Mora; J Blanco
Journal:  J Clin Microbiol       Date:  1997-08       Impact factor: 5.948

10.  Infection prophylaxis in acute leukemia: a comparison of ciprofloxacin with trimethoprim-sulfamethoxazole and colistin.

Authors:  A W Dekker; M Rozenberg-Arska; J Verhoef
Journal:  Ann Intern Med       Date:  1987-01       Impact factor: 25.391

View more
  69 in total

1.  Genotypic analysis of Escherichia coli strains from poultry carcasses and their susceptibilities to antimicrobial agents.

Authors:  I Geornaras; J W Hastings; A von Holy
Journal:  Appl Environ Microbiol       Date:  2001-04       Impact factor: 4.792

2.  Risk factors for fecal quinolone-resistant Escherichia coli in Mexican children.

Authors:  Mussaret B Zaidi; Emma Zamora; Pilar Diaz; Linda Tollefson; Paula J Fedorka-Cray; Marcia L Headrick
Journal:  Antimicrob Agents Chemother       Date:  2003-06       Impact factor: 5.191

3.  The clinical impact of fluoroquinolone resistance in patients with E coli bacteremia.

Authors:  Bernard C Camins; Jonas Marschall; Shannon R DeVader; Dawn E Maker; Matthew W Hoffman; Victoria J Fraser
Journal:  J Hosp Med       Date:  2011 Jul-Aug       Impact factor: 2.960

4.  Virulence genotype and phylogenetic origin in relation to antibiotic resistance profile among Escherichia coli urine sample isolates from Israeli women with acute uncomplicated cystitis.

Authors:  James R Johnson; Michael A Kuskowski; Timothy T O'bryan; Raul Colodner; Raul Raz
Journal:  Antimicrob Agents Chemother       Date:  2005-01       Impact factor: 5.191

5.  Independent behavior of commensal flora for carriage of fluoroquinolone-resistant bacteria in patients at admission.

Authors:  Victoire de Lastours; Françoise Chau; Florence Tubach; Blandine Pasquet; Etienne Ruppé; Bruno Fantin
Journal:  Antimicrob Agents Chemother       Date:  2010-09-27       Impact factor: 5.191

6.  Detection of Salmonella spp. in retail raw food samples from Vietnam and characterization of their antibiotic resistance.

Authors:  Thi Thu Hao Van; George Moutafis; Taghrid Istivan; Linh Thuoc Tran; Peter J Coloe
Journal:  Appl Environ Microbiol       Date:  2007-08-31       Impact factor: 4.792

7.  Emergence of reduced susceptibility and resistance to fluoroquinolones in Escherichia coli in Taiwan and contributions of distinct selective pressures.

Authors:  L C McDonald; F J Chen; H J Lo; H C Yin; P L Lu; C H Huang; P Chen; T L Lauderdale; M Ho
Journal:  Antimicrob Agents Chemother       Date:  2001-11       Impact factor: 5.191

8.  Prospective assessment of fluoroquinolone use in a teaching hospital.

Authors:  M Méan; P Pavese; J P Vittoz; L Foroni; C Decouchon; J P Stahl; P François
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2006-12       Impact factor: 3.267

Review 9.  Defining relatedness in studies of transmission of antimicrobial-resistant organisms: variability in definitions across studies and impact of different approaches on study conclusions.

Authors:  Rachel M Greenblatt; Jennifer H Han; Irving Nachamkin; Pam Tolomeo; Ebbing Lautenbach
Journal:  Infect Control Hosp Epidemiol       Date:  2012-11-21       Impact factor: 3.254

10.  Reduced fluoroquinolone susceptibility in Salmonella enterica serotypes in travelers returning from Southeast Asia.

Authors:  A Hakanen; P Kotilainen; P Huovinen; H Helenius; A Siitonen
Journal:  Emerg Infect Dis       Date:  2001 Nov-Dec       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.